Alzheimer’s team tackles a daunting R&D field with a new game plan

The drug is tramiprosate, which flunked a big study back in 2009. It’s been rebuilt, so to speak, so it can be delivered through the gut in such a way as it can deliver a higher dose where it’s needed in the brain.

As quoted from fiercebiotech.com.  Read the full article here
2016-12-06T09:28:19+00:00 October 23rd, 2013|Tags: |